News Release

Pacira Pharmaceuticals, Inc. to Present at November Investor Conferences

PARSIPPANY, N.J.--(BUSINESS WIRE)--Nov. 1, 2013-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave Stack, president, chief executive officer and chairman of Pacira Pharmaceuticals, is scheduled to present an overview of the company at investor conferences during November.

  • Mr. Stack will present at the Goldman Sachs US Emerging / SMID Cap Growth Conference on Thursday, November 14, 2013, at 2:40 p.m. ET in New York.
  • Mr. Stack will present at the Jefferies 2013 Global Healthcare Conference on Thursday, November 21, 2013, at 9:20 a.m. BST (4:20 a.m. ET) in London, UK.

A live audio webcast of these Pacira presentations can be accessed by visiting the “Investors & Media” section of the company’s website at investor.pacira.com. Replays of the webcasts will be archived on the Pacira website for two weeks following the presentation dates.

About Pacira

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.

Source: Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc.
Jessica Cho, 973-254-3574
Investor Relations Associate
Jessica.Cho@pacira.com